TG THERAPEUTICS, INC.

TGTX

TG THERAPEUTICS, INC.

TGTX

Insider Sentiment (TTM):

Last Purchase:2023-08-11Last Sale:2025-11-24Shares Purchased (TTM):0Shares Sold (TTM):25,852

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:103,476,318Shares Outstanding:144,439,370Institutional Ownership Pct.:71.64%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	483	442	79	74	129	132	180	196	83	75	93	151
Short Term Investments	70	72	63	58	123	144	131	145	134	134	125	78
Receivables Net Current	-	-	-	-	-	-	-	-	-	-	-	39
Accounts Receivable Net Current	402	392	306	265	232	190	129	116	84	65	51	-
Inventory Net	148	129	126	147	155	158	110	85	81	78	40	34
Other Assets Current	44	51	58	56	25	20	16	33	7	8	10	12
Assets Current	1,146	1,087	631	600	664	645	566	574	389	361	318	319
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Long Term Investments	64	62	59	49	29	2	1	1	1	1	0	0
Operating Lease Right Of Use Asset	7	6	6	7	7	7	7	7	8	8	8	8
Property Plant And Equipment Net	-	-	-	-	-	-	-	-	-	0	0	0
Deferred Income Tax Assets Net	343	344	348	367	-	-	0	-	-	-	-	-
Inventory Noncurrent	75	26	16	-	-	-	0	-	-	-	-	-
Other Assets Noncurrent	2	2	2	2	2	2	2	2	2	-	2	-
Assets	1,640	1,529	1,063	1,025	703	657	578	586	401	373	330	331
Liabilities Current
Goodwill	-	-	-	-	-	-	-	-	-	1	1	1
Accounts Payable And Accrued Liabilities Current	214	149	108	112	134	134	58	101	93	87	38	40
Other Liabilities Current	1	1	2	2	2	3	5	3	4	4	1	1
Operating Lease Liability Current	2	2	1	1	1	1	1	1	1	1	1	1
Deferred Revenue Current	17	17	21	26	24	17	11	9	3	3	0	7
Deferred Compensation Liability Current	35	19	22	15	11	5	15	10	6	4	12	8
Liabilities Current	268	187	154	157	172	160	91	125	109	100	54	58
Deferred Revenue Noncurrent	15	7	9	8	2	7	12	16	4	3	6	0
Long Term Debt Noncurrent	745	745	246	245	245	245	244	244	103	101	100	99
Operating Lease Liability Noncurrent	7	7	7	7	8	8	8	8	9	9	9	10
Liabilities	1,036	946	415	418	426	419	355	394	224	213	169	166
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,859	1,845	1,830	1,812	1,794	1,776	1,760	1,747	1,734	1,685	1,713	1,665
Treasury Stock Value	-	-	-100	-100	-	-	-9	-	-	-	-	-
Treasury Stock Common Value	-200	-200	-	-	-22	-15	-9	-2	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,054	-1,062	-1,082	-1,105	-1,496	-1,524	-1,529	-1,553	-1,556	-1,525	-1,553	-1,500
Stockholders Equity	604	583	648	607	276	237	222	192	178	160	161	165
Liabilities And Stockholders Equity	1,640	1,529	1,063	1,025	703	657	578	586	401	373	330	331
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	190	190	190	190	190	190	190	190	190	175	175	175
Common Stock Shares Issued	160	160	159	159	159	159	156	156	155	155	151	151
Shares Outstanding	153	153	155	155	158	158	156	156	155	155	151	151
Treasury Stock Common Shares	7	7	4	4	1	1	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.60%	33.02%	33.52%	-	-	-	-	-	-	-	-	-
2025	4.37%	9.16%	9.69%	9.81%	32.91%	24.80%	-2.29%	-9.61%	-8.34%	-0.07%	17.41%	31.27%
2024	-1.27%	7.75%	24.56%	17.92%	19.63%	17.27%	24.73%	16.59%	12.04%	15.80%	20.08%	0.44%
2023	-	-	-	-	-	-	34.93%	66.63%	54.15%	-10.05%	-19.98%	-4.30%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.27	5.81	4.10	3.82	3.86	4.02	6.25	4.59	3.58	3.62	5.92	5.53
Quick Ratio	3.72	5.12	3.29	2.89	2.96	3.04	5.03	3.91	2.83	2.84	5.18	4.95
Working Capital	877.19M	899.86M	477.00M	442.96M	492.07M	484.30M	475.68M	448.96M	280.49M	260.90M	264.22M	261.44M
Leverage & Debt
Debt to Equity	1.71	1.62	0.64	0.69	1.54	1.77	1.60	2.05	1.26	1.33	1.05	1.01
Interest Coverage TTM	3.64	5.41	4.61	3.79	2.75	2.10	1.75	-0.03	8.21	4.01	1.64	-1.45
Debt Ratio	0.63	0.62	0.39	0.41	0.61	0.64	0.62	0.67	0.56	0.57	0.51	0.50
Efficiency & Turnover
Asset Turnover TTM	0.68	0.64	0.75	0.66	0.82	0.75	0.73	0.58	1.11	1.01	0.89	0.69
Days Sales Outstanding TTM	144.51	151.70	128.76	130.76	126.66	120.49	100.00	106.86	53.21	46.43	79.81	75.63
Receivables Turnover TTM	2.53	2.41	2.83	2.79	2.88	3.03	3.65	3.42	6.86	7.86	4.57	4.83
Per Share Metrics
Diluted EPS TTM	2.81	2.89	2.77	2.78	0.37	0.24	0.15	-0.09	0.60	0.28	0.09	-0.17
Free Cash Flow Per Share TTM	0.12	-0.10	-0.17	-0.48	-0.40	-0.42	-0.28	-0.19	0.47	0.14	-0.22	-0.29
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	82.37%	83.05%	83.66%	85.34%	86.96%	87.43%	88.30%	88.32%	92.76%	93.53%	93.95%	96.55%
Operating Profit Margin TTM	17.05%	21.35%	20.01%	19.32%	18.91%	15.48%	12.74%	-0.19%	29.37%	16.71%	8.83%	-9.98%
Net Profit Margin TTM	55.22%	65.95%	72.56%	84.13%	13.31%	10.13%	7.11%	-5.42%	27.60%	14.24%	5.42%	-13.65%
Growth Metrics
Net Revenue Growth (1Y)	76.08%	81.26%	87.32%	100.88%	30.96%	33.54%	40.80%	39.53%	1,341.56%	3,275.33%	8,290.02%	3,676.58%
Net Income Growth (1Y)	630.24%	1,079.81%	1,812.41%	-3,215.24%	-36.82%	-4.97%	84.52%	-44.55%	-154.47%	-124.44%	-106.39%	-89.15%
EPS Growth (1Y)	655.84%	1,098.09%	1,825.67%	-3,208.50%	-37.68%	-5.27%	80.26%	-45.41%	-153.26%	-123.46%	-106.09%	-89.72%
Valuation Metrics
P/E TTM	17.64	10.39	9.62	11.74	87.35	147.73	187.06	-236.28	26.91	53.98	191.33	-46.11
P/B TTM	12.89	8.23	6.64	8.65	19.10	24.37	19.67	17.66	14.50	13.89	15.11	7.25
P/S TTM	9.74	6.85	6.98	9.88	11.63	14.97	13.29	12.82	7.43	7.69	10.38	6.29
Market Cap	7.79B	4.80B	4.30B	5.25B	5.28B	5.78B	4.37B	3.39B	2.57B	2.22B	2.42B	1.19B
Enterprise Value	8.05B	5.10B	4.47B	5.42B	5.40B	5.90B	4.44B	3.44B	2.59B	2.25B	2.43B	1.14B
Calculated Values
Free Cash Flow TTM	17.39M	-14.19M	-24.99M	-70.24M	-59.24M	-61.10M	-40.56M	-28.11M	67.82M	20.28M	-31.41M	-42.08M
Net Debt	261.45M	301.58M	165.16M	169.93M	115.91M	112.59M	64.54M	48.34M	19.63M	25.85M	5.90M	-51.99M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-24Sale

Owner: Echelard, Yann

Title: -

Shares: 5,000

Price/Share: $32.57

Value: $162,850.00

Shares Owned: 223,816

Relationship: Director

Ownership: Direct

2025-09-11Sale

Owner: Lonial, Sagar

Title: -

Shares: 20,852

Price/Share: $32.24

Value: $672,268.48

Shares Owned: 94,061

Relationship: Director

Ownership: Direct

2025-06-13Sale

Owner: Echelard, Yann

Title: -

Shares: 10,000

Price/Share: $36.94

Value: $369,400.00

Shares Owned: 228,816

Relationship: Director

Ownership: Direct

2025-01-06Sale

Owner: Power, Sean A

Title: CFO

Shares: 10,021

Price/Share: $28.53

Value: $285,899.13

Shares Owned: 660,611

Relationship: Officer

Ownership: Direct

2024-11-11Sale

Owner: Charney, Laurence N

Title: -

Shares: 25,000

Price/Share: $30.20

Value: $755,000.00

Shares Owned: 212,479

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-24	Echelard, Yann	Director	-	Direct	Sale	5,000	32.57	$162,850.00	223,816	4
2025-09-11	Lonial, Sagar	Director	-	Direct	Sale	20,852	32.24	$672,268.48	94,061	4
2025-06-13	Echelard, Yann	Director	-	Direct	Sale	10,000	36.94	$369,400.00	228,816	4
2025-01-06	Power, Sean A	Officer	CFO	Direct	Sale	10,021	28.53	$285,899.13	660,611	4
2024-11-11	Charney, Laurence N	Director	-	Direct	Sale	25,000	30.20	$755,000.00	212,479	4
2024-11-11	Lonial, Sagar	Director	-	Direct	Sale	5,000	30.44	$152,200.00	100,195	4
2024-11-05	Echelard, Yann	Director	-	Direct	Sale	20,000	24.48	$489,600.00	224,098	4
2024-06-20	Lonial, Sagar	Director	-	Direct	Sale	16,348	16.87	$275,790.76	105,195	4
2024-03-13	Lonial, Sagar	Director	-	Direct	Sale	5,000	15.94	$79,700.00	108,878	4
2024-03-12	Charney, Laurence N	Director	-	Direct	Sale	22,000	15.97	$351,340.00	215,229	4
2024-01-05	Charney, Laurence N	Director	-	Direct	Sale	17,500	19.03	$333,025.00	237,229	4
2024-01-03	Power, Sean A	Officer	CFO	Direct	Sale	47,867	16.91	$809,430.97	606,969	4
2023-08-11	Weiss, Michael S	Director,Officer	CEO and President	Direct	Purchase	100,000	10.13	$1,013,000.00	12,073,021	4
2023-06-23	Lonial, Sagar	Director	-	Direct	Sale	34,854	23.37	$814,537.98	93,878	4
2023-06-02	Power, Sean A	Officer	Chief Financial Officer	Direct	Sale	73,647	26.70	$1,966,374.90	654,836	4
2023-01-06	Echelard, Yann	Director	-	Direct	Purchase	9,000	10.64	$95,760.00	201,848	4
2023-01-04	Charney, Laurence N	Director	-	Direct	Sale	30,000	11.10	$333,000.00	234,729	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

71.64%

Inst. Shares: 103,476,318

Shares Outstanding: 144,439,370

2025-12-31

69.85%

Inst. Shares: 100,811,978

Shares Outstanding: 144,316,786

2025-09-30

66.46%

Inst. Shares: 96,639,043

Shares Outstanding: 145,416,901

2025-06-30

66.52%

Inst. Shares: 97,615,569

Shares Outstanding: 146,739,833

2025-03-31

65.49%

Inst. Shares: 96,064,146

Shares Outstanding: 146,677,783

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	103,476,318	144,439,370	71.64%
2025-12-31	100,811,978	144,316,786	69.85%
2025-09-30	96,639,043	145,416,901	66.46%
2025-06-30	97,615,569	146,739,833	66.52%
2025-03-31	96,064,146	146,677,783	65.49%
2024-12-31	94,651,047	145,317,418	65.13%
2024-09-30	98,822,575	145,102,479	68.11%
2024-06-30	90,849,941	144,727,482	62.77%
2024-03-31	86,529,769	146,209,213	59.18%
2023-12-31	87,762,770	141,955,112	61.82%
2023-09-30	86,694,768	142,871,227	60.68%
2023-06-30	84,668,714	141,503,738	59.83%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

TG THERAPEUTICS, INC. (TGTX) — SEC Financial Statements & Analysis

TG THERAPEUTICS, INC. (TGTX) is a pharmaceutical preparations company, incorporated in DE. TG THERAPEUTICS, INC. trades on Nasdaq as: TGTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), TG THERAPEUTICS, INC. reported a 76.08% year-over-year revenue growth, a Gross Profit Margin of 82.37% (TTM), a Debt-to-Equity ratio of 1.71x, a Price-to-Sales (P/S) ratio of 9.74x (TTM), a Price-to-Book (P/B) ratio of 12.89x (TTM), at a market cap of $7.79B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 76.08%
Gross Profit Margin TTM: 82.37%
Debt To Equity: 1.71x
P/S TTM: 9.74x
P/B TTM: 12.89x
Market Cap: $7.79B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TG THERAPEUTICS, INC. in?

TG THERAPEUTICS, INC. (TGTX) operates in the Pharmaceutical Preparations industry.

What is TGTX's market cap?

TG THERAPEUTICS, INC. (TGTX) has a market capitalization of $7.79B as of 2026-06-30.

What is TGTX's P/E ratio?

TG THERAPEUTICS, INC. (TGTX)'s trailing twelve month P/E ratio is 17.64x as of 2026-06-30.

What exchange does TGTX trade on?

TG THERAPEUTICS, INC. (TGTX) trades on the Nasdaq.

Where is TG THERAPEUTICS, INC. incorporated?

TG THERAPEUTICS, INC. is incorporated in DE.